Prospera Financial Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-8,872
Closed -$573K – 1613
2026
Q2
$573K Buy
+8,872
New +$486K 0.01% 979
2022
Q2
– Sell
-176
Closed -$6K – 2421
2022
Q1
$6K Buy
+176
New +$6.1K ﹤0.01% 2229
2020
Q4
– Sell
-176
Closed -$7K – 1392
2020
Q3
$7K Buy
+176
New +$7.26K ﹤0.01% 1216
2017
Q1
– Sell
-18,275
Closed -$443K – 414
2016
Q4
$443K Buy
+18,275
New +$438K 0.09% 206

Other funds holding SBIO

Prospera Financial Services's SBIO Position: Q3 2026 in Review

Prospera Financial Services sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2026, closing a stake of 8,872 shares — an estimated $573K sold.

Prospera Financial Services first reported a position in SBIO in Q4 2016 and held it in 4 quarters. The position peaked at $573K in Q2 2026. 35 funds tracked by Wall St. Rank hold SBIO as of Q3 2026.

  • Prospera Financial Services reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2026 after selling out during the quarter.
  • Prospera Financial Services sold 8,872 ALPS Medical Breakthroughs ETF shares in Q3 2026, an estimated $573K.
  • Prospera Financial Services first reported a position in ALPS Medical Breakthroughs ETF in Q4 2016 and held it in 4 quarters.
  • Prospera Financial Services's ALPS Medical Breakthroughs ETF position peaked at $573K in Q2 2026.
  • 35 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2026.

Based on Prospera Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.